NCT03138655 Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) Status COMPLETED Phase PHASE2
NCT03131895 Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants Status COMPLETED Phase PHASE1
NCT03116841 Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory Evaluation Status COMPLETED Phase PHASE4
NCT03101293 A Study to Evaluate the Effect of Food on the Pharmacokinetics of TAK-831 Tablet Formulation Status COMPLETED Phase PHASE1
NCT03092791 IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults Status TERMINATED Phase PHASE1/PHASE2
NCT03090139 Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets Status COMPLETED Phase N/A
NCT03085836 A Pharmacokinetic Study of TAK-438 in Healthy Adult Chinese Participants Status COMPLETED Phase PHASE1
NCT03083639 A Study to Evaluate the Bioequivalence of Single Oral Dose of Esomeprazole Capsule and Tablet Formulation in Healthy Participants Status COMPLETED Phase PHASE1
NCT03079050 An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of Ramadan Status COMPLETED Phase PHASE4
NCT03067506 Cognitive and Mood Assessment Data in Major Depressive Disorder Using Digital Wearable Technology Status COMPLETED Phase N/A
NCT03050359 Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection Status COMPLETED Phase PHASE3
NCT03050307 Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection Status COMPLETED Phase PHASE3
NCT03042325 Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes Mellitus Status WITHDRAWN Phase PHASE4
NCT03042299 A Phase 1, Bio-equivalence Study of TAK-536 Pediatric Formulation Status COMPLETED Phase PHASE1
NCT03039790 Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults Status COMPLETED Phase PHASE2
NCT03035058 Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel Disease Status WITHDRAWN Phase PHASE3
NCT03029143 Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis Status COMPLETED Phase PHASE4
NCT03014479 Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT03010631 Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy Volunteers Status COMPLETED Phase PHASE3